Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway.

Yan H, Ajuwon KM. · 2017

Read Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway. by Yan H, Ajuwon KM. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5487041.txt.

Description

Yan and Ajuwon report a cell study in PLoS ONE on butyrate and the gut barrier. Butyrate is a short-chain fatty acid made by gut microbes. The gut lining blocks toxins and germs while letting nutrients pass. Inflammation can weaken that barrier. The authors test whether butyrate protects it, using pig intestinal cells.

Cells were exposed to LPS, a bacterial toxin that harms the barrier. Butyrate reduced that harm in a dose-dependent way, they report. It raised levels of two tight junction proteins, claudin-3 and claudin-4. It also kept a growth pathway called Akt active despite the toxin. Energy supply in the cells may play a part too.

Catalog record

CREATORYan H, Ajuwon KM.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE51 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5487041

Browse the full library · About the Tower of Babel